In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Celestica, Inc (NYSE: CLS) closed the day trading at $334.57 up 0.82% from the previous closing price of $331.86. In other words, the price has increased by $0.82 from its previous closing price. On the day, 1.64 million shares were traded. CLS stock price reached its highest trading level at $338.58 during the session, while it also had its lowest trading level at $329.36.
Ratios:
For a better understanding of CLS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 125.82 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 96.84. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 1.47. In the meantime, Its Debt-to-Equity ratio is 0.45 whereas as Long-Term Debt/Eq ratio is at 0.43.
On October 16, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $340.
TD Securities Downgraded its Buy to Hold on October 03, 2025, while the target price for the stock was maintained at $238.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 30 ’25 when KOELLNER LAURETTE T bought 6,000 shares for $341.67 per share. The transaction valued at 2,050,025 led to the insider holds 6,000 shares of the business.
Wilson Michael Max sold 25,000 shares of CLS for $2,468,250 on Jan 06 ’25. The Director now owns 1,784 shares after completing the transaction at $98.73 per share. On May 30 ’25, another insider, Agrawal Alok K., who serves as the Former Officer of the company, bought 3,672 shares for $119.47 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLS now has a Market Capitalization of 38487805952 and an Enterprise Value of 38967500800. As of this moment, Celestica,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 54.30, and their Forward P/E ratio for the next fiscal year is 40.06. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.29. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.41 while its Price-to-Book (P/B) ratio in mrq is 18.97. Its current Enterprise Value per Revenue stands at 3.454 whereas that against EBITDA is 34.999.
Stock Price History:
The Beta on a monthly basis for CLS is 1.85, which has changed by 3.123509 over the last 52 weeks, in comparison to a change of 0.15085125 over the same period for the S&P500. Over the past 52 weeks, CLS has reached a high of $363.40, while it has fallen to a 52-week low of $58.05. The 50-Day Moving Average of the stock is 21.79%, while the 200-Day Moving Average is calculated to be 102.06%.
Shares Statistics:
Over the past 3-months, CLS traded about 3.04M shares per day on average, while over the past 10 days, CLS traded about 2800630 shares per day. A total of 115.00M shares are outstanding, with a floating share count of 114.43M. Insiders hold about 0.52% of the company’s shares, while institutions hold 74.84% stake in the company. Shares short for CLS as of 1761868800 were 3385771 with a Short Ratio of 1.11, compared to 1759190400 on 5343990. Therefore, it implies a Short% of Shares Outstanding of 3385771 and a Short% of Float of 2.96.
Earnings Estimates
The performance of Celestica, Inc (CLS) in the stock market is under the watchful eye of 16.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is $1.83, with high estimates of $2.02 and low estimates of $1.71.
Analysts are recommending an EPS of between $6.05 and $5.84 for the fiscal current year, implying an average EPS of $5.93. EPS for the following year is $8.37, with 16.0 analysts recommending between $9.27 and $8.19.
Revenue Estimates
14 analysts predict $3.49B in revenue for. The current quarter. It ranges from a high estimate of $3.62B to a low estimate of $3.35B. As of. The current estimate, Celestica, Inc’s year-ago sales were $2.55BFor the next quarter, 14 analysts are estimating revenue of $3.59B. There is a high estimate of $3.83B for the next quarter, whereas the lowest estimate is $3.49B.
A total of 16 analysts have provided revenue estimates for CLS’s current fiscal year. The highest revenue estimate was $12.35B, while the lowest revenue estimate was $12.09B, resulting in an average revenue estimate of $12.22B. In the same quarter a year ago, actual revenue was $9.65BBased on 16 analysts’ estimates, the company’s revenue will be $16.24B in the next fiscal year. The high estimate is $17.06B and the low estimate is $15.96B.
